Over 50% of Seniors Report Incontinence

More than 50% of older Americans struggle with incontinence, a new government report states.

ED and Men with Gout

Erectile dysfunction (ED) is present and frequently severe in most men with gout, reports new research.

CKD Risk Factors Appear Early

Risk factors for chronic kidney disease (CKD) can be detected 20–30 years before diagnosis.

OTC ED Drug Approval?

Sanofi and Eli Lilly and Company have announced an agreement to pursue FDA approval of Cialis as an OTC treatment for ED.

Walking for Better CKD Outcomes

Walking is associated with a lower risk of overall mortality and a lower risk of renal replacement therapy in patients with chronic kidney disease.

Sexual Adverse Effects of Urology Rx

Data from evaluating sexual function in men with lower urinary tract symptoms was presented at the recent AUA annual meeting.

No Surgery for Overactive Bladder?

Botulinum toxin-A can reduce urinary frequency in refractory overactive bladder, according to a new study.

Chart: BPH Treatments

Review this chart on BPH Treatments for quick information when you need it.

Videos

News

Tainted Sexual Supplement Contains Hidden Ingredient

The FDA is warning consumers not to purchase or use O.M.G., a product marketed for sexual enhancement.

Can Bike Riding Up Prostate Cancer Risk?

A new study fuels the ongoing debate over the health risks of bicycle riding for men: Researchers found that cyclists who bike more may face a higher risk of prostate cancer, but not a greater chance of infertility or erectile dysfunction.

RG-102 Desginated Orphan Drug for Alport Syndrome

The FDA has granted Orphan Drug designation to RG-012 (Regulus), a single stranded, chemically modified oligonucleotide that binds to and inhibits the function of microRNA-21 for the treatment of Alport syndrome.

Kidney Donors Report Insurance Change Woes

A high proportion of kidney donors report difficulty changing or initiating insurance.

Positive Phase 3 Results in Secondary Hyperparathyroidism with AMG 416

Positive Phase 3 results announced for AMG 416 (Amgen) for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease (CKD), receiving hemodialysis.

FEATURES

How to Start a Subspecialty Clinic

How to Start a Subspecialty Clinic

In-house clinics can be a cost-efficient way to provide high-quality healthcare, without having to make a large investment.

Experts Weigh In: Omega-3s and Prostate Cancer

Experts Weigh In: Omega-3s and Prostate Cancer

Some researchers are not convinced that high blood levels of omega-3 fatty acids are associated with an increased PCa risk.

Prostate Cancer Diagnosis: Understanding Symptoms and Screening

Prostate Cancer Diagnosis: Understanding Symptoms and Screening

Prostate cancer is the most common male-related malignancy in the US, the second most common cause of cancer-related death among men.

Featured courses from mycme

FSGS: Talking Points for the Practicing NephrologistExternal web site

From the July 2014 issue of Renal and Urology News: Primary focal segmental glomerulosclerosis (FSGS) ...

CME 1.00 Credits

Sign Up for Free e-newsletters